Hantavirus Cardiopulmonary Syndrome in Canada
Bryce M. Warner, Sebastian Dowhanik
1, Jonathan Audet, Allen Grolla, Daryl Dick
2, James E. Strong, Darwyn Kobasa, L. Robbin Lindsay, Gary Kobinger
3, Heinz Feldmann
4, Harvey Artsob
2, Michael A. Drebot, and David Safronetz
Author affiliations: Public Health Agency of Canada, Winnipeg, Manitoba, Canada (B.M. Warner, S. Dowhanik, J. Audet, A. Grolla, D. Dick, J.E. Strong, D. Kobasa, L.R. Lindsay, G. Kobinger, H. Feldmann, H. Artsob, M.A. Drebot, D. Safronetz); University of Manitoba, Winnipeg (B.M. Warner, J.E. Strong, D. Kobasa, L.R. Lindsay, G. Kobinger, H. Feldmann, M.A. Drebot, D. Safronetz)
Main Article
Figure 2

Figure 2. Cases of hantavirus cardiopulmonary syndrome (HPCS) by province, year, month, and patient age, Canada, 1989–2019. A) HCPS cases per year by province. B) Seasonal incidence of HCPS in Canada as shown by number of cases diagnosed in each month. A clear trend toward spring/summer contraction of disease can be seen. C) HCPS cases by age with associated case-fatality rate. Blue bars indicate the number of cases diagnosed in each age group; red line shows case-fatality rate associated with each age group.
Main Article
Page created: October 08, 2020
Page updated: November 19, 2020
Page reviewed: November 19, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.